Business
Standard BioTools and Visiopharm Announce Partnership for the Development of Complete Image Analysis Solutions to be Packaged With Hyperion and Hyperion+ Imaging Systems
Seamlessly linking the Standard BioTools portfolio of Imaging Mass Cytometry (IMC) systems with Visiopharm AI-driven software for phenotyping cells in
About this update from Standard Biotools Inc.
[{"type":"text","content":"Seamlessly linking the Standard BioTools portfolio of Imaging Mass Cytometry (IMC) systems with Visiopharm AI-driven software for phenotyping cells in high-plex imaging\nSOUTH SAN FRANCISCO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – and Visiopharm® today announced a collaboration to pair the company’s Hyperion™ and Hyperion+™ Imaging Systems with Visiopharm Phenoplex™ analysis software for simplified image processing and enhanced spatial pathology insights, building on the success of a co-marketing agreement announced last year. Visiopharm, a leader in AI-driven digital pathology analysis software, and Standard BioTools, a life science preferred provider of innovative tools for exploratory and translational research, have worked together to develop the first of several specific algorithms and workflows that will provide out-of-the-box solutions and accelerate delivery of results for high-plex imaging studies. The unique Standard BioTools™ single-step staining process and simultaneous 40-plex imaging deliver biomarker-rich data in a single scan for tissue microarrays and formalin-fixed, paraffin-embedded tissue sections, providing enough datapoints to thoroughly phenotype and decipher cellular composition and function. Integrating Phenoplex into Hyperion and Hyperion+ Imaging Systems will bring a powerful, unified image analysis pipeline to Imaging Mass Cytometry™ (IMC™) users, who will be able to more easily extract and more quickly act on meaningful biological data from their IMC investigations. This close partnership offers one of the most effective solutions to date, in which Visiopharm software reads native MCD files, the output image file from Standard BioTools imaging systems, directly linking MCD™ Viewer to Phenoplex software. Phenoplex then employs the Visiopharm file conversion tool to create pyramidal TIFF images out of MCD files for large image formats that contain more markers for deeper analysis. The Phenoplex workflow includes an AI tissue segmentation step, an AI-based nuclear segmentation step, cellular boundary detection that can include use of the Standard BioTools IMC Cell Segmentation Kit, cellular phenotyping, data exploration and image QC, spatial analyses, and a wide range of data/...